Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carina S. Debes-Marun
Observed names:
C S Debes-Marun,
C.S. Debes Marun,
Carina Debes Marun,
Carina Debes-Marun,
Carina S. Debes Marun
Institutions:
University of Alberta,
Cross Cancer Institute
Observed institutions:
Alberta Health Services,
Mayo Clinic,
University of Alberta,
Eastern Cooperative Oncology Group,
Dana-Farber Cancer Institute,
Cross Cancer Institute
show all 6
OpenAlex ID:
A5035675501
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
2003
·
Rafael Fonseca
, Carina S. Debes-Marun
, et al.
·
Blood
·
296
PDF
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
2003
·
C S Debes-Marun
, G W Dewald
, et al.
·
Leukemia
·
227
A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma
2008
·
Julia Kirshner
, Kyle J. Thulien
, et al.
·
Blood
·
126
PDF
FISH and chips: chromosomal analysis on microfluidic platforms
2007
·
V.J. Sieben
, C.S. Debes Marun
, et al.
·
IET Nanobiotechnology
·
62
An integrated microfluidic chip for chromosome enumeration using fluorescence in situ hybridization
2008
·
Vincent J. Sieben
, Carina S. Debes-Marun
, et al.
·
Lab on a Chip
·
51
Frequent Occurrence of Highly Expanded but Unrelated B-Cell Clones in Patients with Multiple Myeloma
2013
·
Jitra Kriangkum
, Sarah N. Motz
, et al.
·
PLoS ONE
·
16
PDF
In multiple myeloma, bone‐marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival
2012
·
Carina S. Debes Marun
, Andrew R. Belch
, et al.
·
American Journal of Hematology
·
9
PDF
CAR T Cell Exhaustion but Not Ex Vivo Cytotoxicity Is Predictive of Patient Clinical Response: An Interim Analysis of ACIT001/EXC002, a Phase Ib/II Trial of Decentralized Production of CAR T Cells for Treatment of Relapsed/Refractory Aggressive NHL and ALL
2023
·
Charles Yin
, Bindu Thapa
, et al.
·
Blood
·
8
Circulating B Lymphocytes from Patients with Multiple Myeloma Harbour T(4;14) Translocations and Chromosome 13 Deletions.
2005
·
Carina Debes-Marun
, Andrew R. Belch
, et al.
·
Blood
·
7
Alberta Cellular and Immunotherapy (ACIT) 001, Updated Results of Decentralized Production of Second Generation, Anti-CD19/41BB/CD3z Chimeric Antigen Receptor (CAR) T-Cells in Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL)
2024
·
Michael P. Chu
, Zack Breckenridge
, et al.
·
Blood
·
3
Second Clones In Molecularly-Defined Biclonal Multiple Myeloma Are Derived From Unrelated B Cells, Can Be Present at High Frequency and Exhibit Chromosomal Abnormalities
2010
·
Jitra Kriangkum
, Carina Debes Marun
, et al.
·
Blood
·
1
on multiple myeloma A unique three-dimensional model for evaluating the impact of therapy
2008
·
Linda M. Pilarski
, Julia Kirshner
, et al.
·
1
An Integrated Microfluidic Fish Chip: Enumerating Chromosomes on a Cell-by-cell Basis in Less Than 1 Hour
2008
·
Vincent J. Sieben
, Carina Debes-Marun
, et al.
·
1
A Unique Pre-Clinical Model Providing Access to a Drug Resistant Population within the Multiple Myeloma Stem Cell Niche in a Novel 3-D Culture System for Bone Marrow.
2007
·
Julia Kirshner
, Kyle J. Thulien
, et al.
·
Blood
·
1
Individualizing apheresis processing volumes using a predictive algorithm: Analysis of the CAR T-cell collection protocol utilized in ACIT001/EXC002, a phase lb/ll trial of decentralized production of CAR T-cells for treatment of relapsed/refractory aggressive NHL and ALL
2025
·
Jennifer Croden
, Zackariah Breckenridge
, et al.
·
Blood
PDF
Lipid nanoparticle-mediated mRNA transfection enables efficient and safe generation of CAR macrophages.
2025
·
Felix Chiu
, Angela Hamie
, et al.
·
Blood
PDF
Gene Expression Profile of Enriched T-Cells Prior to Chimeric Antigen Receptor (CAR) T-Cell Manufacturing Is Predictive of CAR T-Cell Response
2024
·
Bee S Tan
, Charles Yin
, et al.
·
Blood
PDF
Alberta Cellular and Immunotherapy (ACIT) 001, Results of Decentralized Production of Second Generation, Anti-CD19/41BB/CD3z Chimeric Antigen Receptor (CAR) T-Cells in Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL)
2022
·
Michael P. Chu
, Zack M. Breckenridge
, et al.
·
Blood
Predicting Response of CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL) in ACIT001/EXC002, a Phase Ib Clinical Trial
2022
·
Bindu Thapa
, Carina Debes-Marun
, et al.
·
Blood
Real-time prediction of myeloma clinical responses using an ex vivo, 3-dimensional culture system
2019
·
Michael Chu
, Carina Debes-Marun
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Chromosomal Abnormalities in Bone Marrow Lymphocytes of MM Patients
2010
·
Carina S. Debes Marun
, Andrew Belch
, et al.
·
Blood
Molecular Biclonality: Analysis of Clonotypic IgH VDJ Reveals the Frequent Occurrence of a Second Clone in Multiple Myeloma.
2009
·
Jitra Kriangkum
, Sarah Motz
, et al.
·
Blood
FISH and Chips: Novel, Point of Care Technology To Detect Chromosomal Abnormalities.
2006
·
Carina S. Debes Marun
, Vincent Sieben
, et al.
·
Blood
Show more works
View as search
Works count:
23
Citation count:
809
H-index:
8
I10-index:
6
Year
Topic
Type
